Am J Transplant, Volume 16, Suppl 3 Archives - Page 127 of 180 - ATC Abstracts

2016 American Transplant Congress
Optimal Donor/Recipient Pairing for High KDPI Grafts Can Yield Similar Survival to Medium KDPI Grafts.
M. Selim, E. Saad, M. Zimmerman, C. Johnson.
Medical College of Wisconsin, Milwaukee.
KDPI is a predictor of deceased-donor (DD) graft survival, calculated using donor factors. It does not consider recipient or other post-procurement factors. This retrospective analysis…
2016 American Transplant Congress
Molecular Significance of Microvascular Inflammation and C4d Negative Transplant Glomerulopathy.
M. Lubetzky,¹ P. O Broin,² Y. Bao,¹ E. Akalin.¹
¹Transplantation, Albert Einstein College of Medicine, Bronx; ²School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway University, Galway, Ireland.
Background: Transplant glomerulopathy (TGP) is frequently found in the setting of chronic antibody mediated rejection along with microvascular inflammation (MVI) (peritubular capillaritis+glomerulitis score > 1)…
2016 American Transplant Congress
High Efficacy of Ledipasvir/Sofosbuvir with Ribavirin in HCV Genotype-1 Infected Patients with Decompensated Liver Disease: Analysis by MELD Score from the SOLAR-1 and SOLAR-2 Trials.
M. Charlton,¹ E. Yoshida,² M. Bouliere,³ S. Flamm,⁴ A. Muir,⁵ M. Fried,⁶ N. Terrault,⁷ S. Arterburn,⁸ C. Yun,⁸ P. Pang,⁸ A. Osinusi,⁸ J. Spellman,⁸ M. Natha,⁸ D. Brainard,⁸ J. McHutchison,⁸ M. Manns,⁹ N. Afdhal.¹⁰
¹Intermountain Medical Center, Salt Lake City; ²Vancouver General Hospital, Vancouver, Canada; ³Hopital Saint Joseph, Marseilles, France; ⁴Northwestern University, Chicago; ⁵Duke University, Durham; ⁶University of North Carolina, Chapel Hill; ⁷UCSF, SF; ⁸Gilead Sciences Inc, Foster City; ⁹Hannover Medical School, Hannover, Germany; ¹⁰BIDMC, Boston.
Introduction: HCV infected patients with decompensated liver disease have significant morbidity & mortality. The efficacy & safety of LDV/SOF + RBV was evaluated in a…
2016 American Transplant Congress
Early Post Renal Transplant aHUS in Patients with Heterozygous CFHR3-CFHR1 Deletion.
S. Rhazouani, A. Malone, T. Alhamad, T. Maw, D. Brennan, R. Delos Santos.
Renal Division, Washington University, Saint Louis, MO.
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare disease with a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Subjects homozygous for…
2016 American Transplant Congress
Learning Curve of Laparoscopic Donor Nephrectomy for Abdominal Transplant Surgery Fellows.
O. Serrano,¹ A. Bangdiwala,² D. Vock,³ V. Kirchner,¹ T. Dunn,¹ E. Finger,¹ T. Pruett,¹ A. Matas,¹ R. Kandaswamy.¹
¹Surgery, Univ. of Minnesota, Minneapolis, MN; ²Biostatistics, Masonic Cancer Center, Minneapolis, MN; ³Biostatistics, Univ. of Minnesota, Minneapolis, MN.
PURPOSE: Laparoscopic donor nephrectomy (LDN) requires a high degree of surgical competence and skill. UNOS recommends that fellowship-trained surgeons participate in 15 LDN to be…
2016 American Transplant Congress
Phenotype and Outcome of Antibody-Mediated Rejection Due to Pre-Existing and De Novo DSA in Kidney Recipients.
O. Aubert,¹ A. Loupy,¹ L. Hidalgo,² J. Reeve,³ D. Glotz,¹ C. Legendre,¹ C. Lefaucheur,¹ P. Halloran.³
¹Paris Research Center for Organ Transplantation, Paris, France; ²University of Alberta, Edmonton, Canada; ³ATAGC, Edmonton, Canada.
Antibody-mediated rejection (ABMR) presents with either pre-existing or de novo DSA. The aim of the study was to compare the two ABMR phenotypes and their…
2016 American Transplant Congress
Lower Rates of Living Donor Kidney Transplantation(LD) Among African Americans: What Prevents Higher Rates of Donation?
A. Li, N. Foreman, M. Reissmann, C. Zuttermeister, A. Gilbert, M. Grafals, B. Javaid, S. Ghasemian, P. Abrams, M. Cooper, J. Verbesey.
MedStar Georgetown Transplant Institute, Washington, DC.
Purpose: African Americans (AA) are less likely to undergo LD kidney transplantation. Reasons may include decreased health literacy, increased obesity, or hypertension. We sought to…
2016 American Transplant Congress
Implications of Subclinical Borderline Acute Cellular Rejection Detected in Protocol Biopsies on Graft Outcomes.
Z. Zaky,¹ C. Yu,¹ N. Elfadawy,² A. Chiesa-Vottero,¹ L. Herlitz,¹ S. Flechner,¹ E. Poggio.¹
¹Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH; ²Internal Medicine, Univ. Hospitals Case Medical Center, Cleveland, OH.
Background: The effects of subclinical borderline acute cellular rejection (BACR-defined as I1T1 per Banff criteria) detected in protocol biopsies (Bx) on subsequent graft function and…
2016 American Transplant Congress
Removing Geographic and Financial Barriers for Directed Living Kidney Donations: Lessons from Kidney Paired Donation.
M. Aeder,¹ R. Leishman,² D. Stewart.²
¹Univ Hosp Case Med Ctr, Cleveland, OH; ²UNOS, Richmond, VA.
Living donor (LD) kidney (K) transplants (Tx), which peaked at 6647 in 2004 (42.5% of tx), decreased by 2014 to 5538 (32.4% of tx). Although…
2016 American Transplant Congress
ABO Incompatible Living Related Kidney Transplantation: Results of a Matched-Pair Analysis with ABO Compatible Living Donation.
T. Vowinkel,¹ H. Wolters,² S. Reuter,³ T. Vogel,¹ N. Senninger,¹ B. Suwelack.³
¹Department of General and Visceral Surgery, University Hospital Muenster, Muenster, Germany; ²Department of General and Visceral Surgery, St. Josef's Hospital, Dortmund, Germany; ³Department of Internal Medicine D, University Hospital Muenster, Muenster, Germany.
Background: Organ shortage has led to an increase in living related kidney transplantation of ABO compatible (ABOc) as well as ABO incompatible (ABOi) organs. Here…